Trade Summary

1 week ago, Kalif Eliyahu Sharon, serving as EVP, CFO at Teva Pharmaceutical Industries Ltd (TEVA), sold 153,251 shares at $35.61 per share, for a total transaction value of $5,457,375.00. Following this transaction, Kalif Eliyahu Sharon now holds 172,184 shares of TEVA.

This sale represents a 47.00% decrease in Kalif Eliyahu Sharon's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 14, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 4:00 PM ET, 4 days after the trade was made.

Teva Pharmaceutical Industries Ltd operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.